Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Teva Pharmaceutical Industries Insider Sold Shares Worth $285,215, According to a Recent SEC Filing

Teva Pharmaceutical Industries Insider Sold Shares Worth $285,215, According to a Recent SEC Filing

MT newswireMT newswire2026/09/22 21:06
05:06 PM EDT, 09/22/2026 (MT Newswires) -- Brian Savage, Interim Chief Legal Officer, on September 18, 2026, sold 7,342 shares in Teva Pharmaceutical Industries (TEVA) for $285,215. Following the Form 4 filing with the SEC, Savage has control over a total of 8,500 ordinary shares of the company, with 8,500 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/818686/000119312526398105/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Novo Nordisk (NVO.US) considers entering the hair loss market, seeking new growth points with its "post-Wegovy" strategy

Novo Nordisk is targeting the hair loss market, seeking to diversify its drug portfolio.

智通财经2026/09/23 00:31

The growth of the traditional network equipment industry may have peaked! Piper Sandler lowers Cisco (CSCO.US) target price to 125 USD.

Piper Sandler analyst James Fish maintains a "Neutral" rating on Cisco, while lowering the target price from $132 to $125.

智通财经2026/09/23 00:31